Skip to content
OpenCapital
Get started

Madrigal Pharmaceuticals, Inc. MDGL Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

MSCI logo
MSCIMSCI
410K-15.5%
3M logo
3MMMM
6.4K-9.9%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
4.1M—
PPG Industries logo
PPG IndustriesPPG
714.1K+10.8%
RBC Bearings logo
RBC BearingsRBC
46.1K+3.9%
EFC
Ellington Financial Inc.EFC
18.4K+9.8%

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M—
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M—
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%—
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number?
Madrigal Pharmaceuticals, Inc. (MDGL) reported share-based payment award options outstanding - number of 1M in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number decreased by 33.3% year-over-year, from 1.5M to 1M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number?
Over 2 years (2023 to 2025), Madrigal Pharmaceuticals, Inc.'s share-based payment award options outstanding - number has grown at a -35.5% compound annual growth rate (CAGR), from 2.4M to 979.9K.